FP7
BIO-DrIM
Personalized minimization of immunosuppression after solid organ transplantation by biomarker-driven stratification of patients to improve long-term outcome and health-economic data of transplantation
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 60 months
- Total cost
- EUR 7,978,285
- EU contribution
- EUR 5,989,000
- Participants
- 16 from 7 countries
- Topic
- FP7_HEALTH.2012.1.4-1
- Grant agreement
- 305147
Coordinated by Charite - Universitaetsmedizin Berlin (DEGermany).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Charite - Universitaetsmedizin Berlin | DEGermany | Coordinator | EUR 1,344,168 | PIC (1.00) |
| Institut klinické a experimentální mediciny | CZCzechia | Participant | EUR 500,000 | known name (0.95) |
| Bristol-Myers Squibb GmbH & Co. Kgaa | DEGermany | Participant | Not stated | PIC (1.00) |
| Cellogic GmbH | DEGermany | Participant | EUR 199,200 | PIC (1.00) |
| Genome Identification Diagnostics GmbH | DEGermany | Participant | EUR 611,000 | PIC (1.00) |
| Klinikum der Universitaet Regensburg | DEGermany | Participant | EUR 201,600 | PIC (1.00) |
| Milenia Biotec GmbH | DEGermany | Participant | EUR 89,832 | PIC (1.00) |
| Universitaetsklinikum Hamburg-Eppendorf | DEGermany | Participant | EUR 201,600 | PIC (1.00) |
| Institut Catala de la Salut | ESSpain | Participant | EUR 500,000 | known name (0.95) |
| Centre Hospitalier Universitaire de Nantes | FRFrance | Participant | EUR 500,000 | known name (0.95) |
| Immunotech Sas | FRFrance | Participant | EUR 114,400 | PIC (1.00) |
| Astellas Pharma Europe Ltd | GBUnited Kingdom | Participant | EUR 76,000 | PIC (1.00) |
| King's College London | GBUnited Kingdom | Participant | EUR 849,660 | known name (0.95) |
| The Chancellor, Masters and Scholars of the University of Oxford | GBUnited Kingdom | Participant | EUR 294,600 | PIC (1.00) |
| Alta Ricerca e Sviluppo in Biotecnologie Srlu | ITItaly | Participant | EUR 229,600 | PIC (1.00) |
| Teva Pharmaceuticals Europe B.V. | NLNetherlands | Participant | EUR 76,000 | PIC (1.00) |
Changes of the consortium
First seen on with 16 participants from 7 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.